Therapeutic strategies for locally recurrent and metastatic de-differentiated liposarcoma with herpes simplex virus-thymidine kinase-expressing mesenchymal stromal cells.

[1]  Gang Li,et al.  Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo. , 2013, Cytotherapy.

[2]  K. Shah,et al.  TRAIL on trial: preclinical advances in cancer therapy. , 2013, Trends in molecular medicine.

[3]  K. Shah,et al.  Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors , 2013, Stem cells.

[4]  M. Han,et al.  A Survey of the Prescription Patterns of Allergen Immunotherapy in Korea , 2013, Allergy, asthma & immunology research.

[5]  A. Lazar,et al.  Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results , 2013, Cancers.

[6]  S. Moon,et al.  A Therapeutic Strategy for Metastatic Malignant Fibrous Histiocytoma Through Mesenchymal Stromal Cell-Mediated TRAIL Production , 2013, Annals of surgery.

[7]  N. Fisk,et al.  Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets? , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[8]  Young Woo Choi,et al.  Complete Regression of Metastatic Renal Cell Carcinoma by Multiple Injections of Engineered Mesenchymal Stem Cells Expressing Dodecameric TRAIL and HSV-TK , 2012, Clinical Cancer Research.

[9]  K. Shah.  Mesenchymal stem cells engineered for cancer therapy. , 2012, Advanced drug delivery reviews.

[10]  A. Lazar,et al.  New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[11]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[12]  A. Lazar,et al.  An experimental model for the study of well differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors , 2010, Laboratory Investigation.

[13]  P. Catalano,et al.  Paclitaxel-Eluting Polymer Film Reduces Locoregional Recurrence and Improves Survival in a Recurrent Sarcoma Model: A Novel Investigational Therapy , 2011, Annals of Surgical Oncology.

[14]  J. Chang,et al.  Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand‐Secreting Human Umbilical Cord Blood‐Derived Mesenchymal Stem Cells in Glioma Therapy , 2010, Stem cells.

[15]  G. Almeida-Porada,et al.  Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. , 2010, Advanced drug delivery reviews.

[16]  C. Naus,et al.  Implications and challenges of connexin connections to cancer , 2010, Nature Reviews Cancer.

[17]  G. Rossi,et al.  Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.

[18]  M. Matúšková,et al.  HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. , 2010, Cancer letters.

[19]  A. Giordano,et al.  The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents. , 2010, World journal of stem cells.

[20]  W. Dernell,et al.  Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas. , 2009, Veterinary and comparative oncology.

[21]  S. de Jong,et al.  TRAIL receptor signalling and modulation: Are we on the right TRAIL? , 2009, Cancer treatment reviews.

[22]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.

[23]  N. Socci,et al.  Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. , 2007, The Journal of clinical investigation.

[24]  H. Neumann,et al.  Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  J. Chan,et al.  Human First‐Trimester Fetal MSC Express Pluripotency Markers and Grow Faster and Have Longer Telomeres Than Adult MSC , 2007, Stem cells.

[26]  S. Gambhir,et al.  Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  A. Uccelli,et al.  Immunoregulatory function of mesenchymal stem cells , 2006, European journal of immunology.

[28]  Cyril Fisher,et al.  Soft-tissue sarcomas in adults. , 2005, The New England journal of medicine.

[29]  P. Guldberg,et al.  Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. , 2005, Cancer research.

[30]  E. Douple,et al.  Biodegradable Cisplatin Polymer in Limb-Sparing Surgery for Canine Osteosarcoma , 2004, Annals of Surgical Oncology.

[31]  J. Czyż,et al.  Gap-junctional coupling measured by flow cytometry. , 2000, Experimental cell research.